News | 02.20.20
Effect of Time of Presentation on Endovascular Treatment Decisions in Acute Stroke Patients
February 19, 2020—An analysis from UNMASK EVT international survey evaluated the relationship of the time of day and endovascular treatment decision-making in acute stroke with relative endovascular treatment indication.
News | 02.12.20
News | 02.10.20
FDA Clears Rist Neurovascular’s Rist Cath for Radial Access
February 10, 2020—Rist Neurovascular, Inc. announced it has received FDA 510(k) clearance to market the Rist Cath radial access long sheath for the introduction of interventional devices into the peripheral, coronary, and neurovascular system.
News | 01.09.20
FDA Approves MicroVention’s Fred Flow Diverter for the Treatment of Intracranial Aneurysms
January 9, 2020—MicroVention, Inc., a United States–based subsidiary of Terumo, announced FDA premarket approval for the Fred (flow-redirection endoluminal device) system for the treatment of intracranial aneurysms.
News | 12.12.19
Effect of BMI Evaluated in Outcomes of Endovascular Treatment for Acute Ischemic Stroke
December 12, 2019—A post hoc analysis of the MR CLEAN trial evaluated the association of body mass index (BMI) and outcomes after endovascular treatment (EVT) in acute ischemic stroke patients with large vessel occlusion (LVO) and assessed whether BMI affects the benefit of EVT.
News | 12.10.19
Financing Will Support Commercialization of Imperative Care’s Stroke Treatments
December 10, 2019—Imperative Care, Inc. announced that it has completed the initial closing of an $85 million Series C financing round to support the commercial launch of the company’s portfolio, which is composed of neurovascular devices to treat ischemic and hemorrhagic strokes.
News | 11.20.19
Viz.ai Introduces New Artificial Intelligence Software Feature for Stroke Care
November 20, 2019—Viz.ai, a company focused on artificial intelligence software applications for stroke treatment, announced the introduction of new software features at SVIN 2019, the annual meeting of the Society of Vascular and Interventional Neurology held November 20–23 in Atlanta, Georgia.
News | 11.05.19
First-in-Human Study Evaluates Anaconda Biomed's Next-Generation Stroke Thrombectomy System
November 5, 2019—Anaconda Biomed, a company developing a next-generation thrombectomy system for the treatment of ischemic stroke, announced the completion of initial patient cases in a first-in-human study at Hospital Vall d’Hebron in Barcelona, Spain.
News | 11.05.19
First Robotic-Assisted Aneurysm Coiling Performed With Corindus' CorPath GRX System
November 5, 2019—Corindus, a Siemens Healthineers company that develops precision vascular robotics, announced that its CorPath GRX system was used to complete the first-in-human robotic-assisted neurovascular intervention.
News | 10.31.19
First Patient Enrolled in CODEX Safety and Feasibility Study of Neural Analytics' Next-Generation Lucid Robotic System
October 31, 2019—Neural Analytics, Inc., a medical robotics company developing and commercializing technologies to measure and track brain health, announced that the first patients were enrolled in the CODEX study of the company’s next-generation Lucid robotic system platform.
News | 10.30.19
News | 10.23.19
Viz.ai Raises Funds to Support Product Development and Commercialization
October 23, 2019—Viz.ai, a developer of synchronized health care software using artificial intelligence, announced a $50 million Series B funding to expand the benefits of synchronized care with the company’s products to more disease states and geographies.
News | 10.21.19
Shape Memory Medical's Trellix Embolic Coil System Approved in Europe
October 21, 2019—Shape Memory Medical Inc. announced it has received CE Mark approval for its Trellix embolic coil system, which is intended to obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
News | 10.15.19
Meta-Analysis Supports Endovascular Thrombectomy to Treat M2 Occlusions
October 15, 2019—A study conducted in response of the Society of Neurointerventional Surgery’s recent revision of its operational definition of emergent large vessel occlusion to include proximal M2 segment middle cerebral artery (MCA) occlusions sought to assess the benefit of endovascular thrombectomy (EVT) over best medical care for this condition.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.